The global capillary blood collection devices market size was estimated to be USD 1.98 billion in 2023 and is expected to reach at USD 5.10 billion by 2034 with a CAGR of 8.96% during the forecast period 2024-2034. Surge in accessibility of Point-of-Care (PoC) diagnostics, an increase in the prevalence of chronic conditions such as diabetes, cardiovascular diseases, & infectious diseases, along with a higher incidence of anemia, rapid urbanization, an uptick in foodborne diseases, the introduction of technologies such as bioanalytical platforms, biosensors, novel assay formats, and other complementary research techniques, surge in adoption of rapid PoC diagnostics, the utilization of capillary blood collection devices are on the rise, and growing introduction of advanced capillary blood collection devices are some of the key factors boosting the market growth.
Growing introduction of advanced capillary blood collection devices is predicted to boost the market growth during the forecast period. Capillary blood collection devices enable swift hematology tests through Point-of-Care (PoC) diagnostics. Unlike the more invasive and costly methods of venous and arterial blood collection, this type of sample gathering is less intrusive, cost-effective, and does not necessitate a skilled professional for the blood drawing process. Consequently, industry participants are launching inventive capillary blood collection devices. For instance, in September 2023, FL Medical SRL has introduced a new blood collection set as part of its Vacumed brand. The Vacumed Tech Blood collection set is specifically crafted to enhance safety, efficiency, and user-friendly experience throughout the collection process.
By product, lancet was the highest revenue-grossing segment in the global capillary blood collection devices market in 2023 owing to the rising demand of disposable lancets due to their frequent utilization in blood draw procedures, particularly for monitoring blood glucose levels in individuals with diabetes who need small blood samples for at-home testing. There is an increasing preference for disposable lancets, and reusable lancet devices are also gaining popularity in home-care settings, particularly for routine glucose and hemoglobin analysis in diabetic and anemic patients. Additionally, micro-container tubes is predicted to grow at fastest CAGR during the forecast period owing to an upward trend in the occurrence of infectious and chronic diseases, a rising acceptance in clinics and hospital settings, and an increasing number of regulatory approvals. For instance, in October 2023, YourBio Health, a Boston-based innovator in remote capillary whole blood collection technology, has disclosed the attainment of additional regulatory approval for its TAP Micro Select blood collection device, securing certification for CE Marking.
By material, plastic was the highest revenue-grossing segment in the global capillary blood collection devices market in 2023 owing to the widespread adoption, user-friendly and cost-effective characteristics, along with the continual introduction of novel products, contribute to the popularity of plastic devices. These devices, commonly utilized in various collection products, are favored for their lightweight nature and biocompatibility with the human body. Over the past few decades, there has been a growing trend in using plastic for manufacturing medical devices. Key factors such as safety, chemical stability, clarity, flexibility, and durability play a significant role in the increasing acceptance of plastic devices in healthcare settings. For instance, in April 2022, Owen Mumford Ltd introduced a new portfolio for venous blood collection under its Unistik brand. Additionally, glass is predicted to grow at fastest CAGR during the forecast period owing to the ease of recyclability, contributing to enhanced environmental sustainability, has led to a growing involvement of manufacturers in producing products and devices based on glass. Glass, distinguished by its high heat resistance, is favored over other materials for manufacturing medical devices. The material's stability, accuracy, and resistance to antimicrobial growth are significant factors driving its widespread adoption.
By application, whole blood tests was the highest revenue-grossing segment in the global capillary blood collection devices market in 2023 owing to Complete blood count (CBC) tests, due to their high frequency and capability to identify a broad spectrum of diseases, are witnessing increased popularity. The prevalence of infectious and chronic diseases like cancer, anemia, autoimmune disorders, and diabetes is on the rise. Additionally, there is a growing trend of collaborations among market players. CBC tests, which are the most commonly performed blood tests, play a crucial role in determining parameters such as white blood cell (WBC) count, red blood cell (RBC) count, hematocrit, hemoglobin, and platelet counts. These tests offer clinicians comprehensive data to identify abnormalities, ensure accurate diagnoses, and are instrumental in monitoring conditions like diabetes and anemia. For instance, in October 2022, BD and Magnolia Medical Technologies Inc have entered into a commercial agreement with the objective of assisting hospitals in the United States to minimize blood culture contamination. This collaboration aims to enhance testing accuracy and, consequently, improve clinical outcomes. Additionally, plasma/ serum protein tests is predicted to grow at fastest CAGR during the forecast period. Plasma tests, also known as protein tests, are employed to assess the levels of proteins in the blood. These tests offer clinicians a comprehensive insight into a patient's health by examining the levels of albumin and globulin. Protein tests are commonly conducted to identify conditions such as liver and kidney disorders, pancreatic disease, intestinal malabsorption, inflammation, nephrotic syndrome, as well as cirrhosis or chronic liver disease.
By end-user, hospitals and clinics was the highest revenue-grossing segment in the global capillary blood collection devices market in 2023 owing to a frequent need for diagnostic testing and a significant influx of patients into these facilities, rising number of surgical procedures, including angioplasty, kidney, and liver transplants, increasing occurrence of trauma injuries, coupled with a heightened research and development expenditure by key industry players. Additionally, home care diagnosis is predicted to grow at fastest CAGR during the forecast period owing to the emergence of innovative devices designed to facilitate convenient and effective diagnosis of diabetic and anemic patients, coupled with a notable increase in partnerships among market players. For instance, in May 2022, Babson Diagnostics, a healthcare technology company focused on scientific advancements, and BD (Becton, Dickinson and Company), a prominent global medical technology company, have expanded their strategic partnership. The collaboration aims to extend blood sample collection to novel care settings, allowing patients to collect blood samples at home for diagnostic testing.
North America region is anticipated for the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, the presence of leading clinical diagnostics firms, growing adoption of advanced technologies, heightened emphasis on clinical research, an increasing number of surgical procedures, a rise in cases related to accidents and trauma, an escalating prevalence of both non-communicable and infectious diseases, and growing launch of innovative devices. For instance, in August 2022, Thermo Fisher Scientific has introduced a new automated system for dried blood spot sampling and analysis. The Thermo Scientific Transcend DSX-1 Integrated Sample Prep and UHPLC System revolutionize the conventional process of dry matrix card punching for sample extraction, accommodating various matrices such as blood, urine, serum, saliva, and more. This system streamlines the collection process, allowing laboratories to efficiently conduct routine analyses of pharmaceuticals and other compounds. The automated system is designed to save substantial time, effort, and reagent costs in comparison to manual workflows. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the escalation in healthcare expenditure, a substantial prevalence of chronic conditions, a surge in health spending, especially for major chronic diseases like diabetes, and an increasing introduction of advanced medical devices. For instance, in September 2022, A team of researchers in South Korea has created a portable, user-friendly, and self-pressure-driven device for blood plasma separation. These devices are designed to work in conjunction with rapid diagnostic test kits.
Growing introduction of advanced capillary blood collection devices is predicted to boost the market growth during the forecast period. Capillary blood collection devices enable swift hematology tests through Point-of-Care (PoC) diagnostics. Unlike the more invasive and costly methods of venous and arterial blood collection, this type of sample gathering is less intrusive, cost-effective, and does not necessitate a skilled professional for the blood drawing process. Consequently, industry participants are launching inventive capillary blood collection devices. For instance, in September 2023, FL Medical SRL has introduced a new blood collection set as part of its Vacumed brand. The Vacumed Tech Blood collection set is specifically crafted to enhance safety, efficiency, and user-friendly experience throughout the collection process.
By product, lancet was the highest revenue-grossing segment in the global capillary blood collection devices market in 2023 owing to the rising demand of disposable lancets due to their frequent utilization in blood draw procedures, particularly for monitoring blood glucose levels in individuals with diabetes who need small blood samples for at-home testing. There is an increasing preference for disposable lancets, and reusable lancet devices are also gaining popularity in home-care settings, particularly for routine glucose and hemoglobin analysis in diabetic and anemic patients. Additionally, micro-container tubes is predicted to grow at fastest CAGR during the forecast period owing to an upward trend in the occurrence of infectious and chronic diseases, a rising acceptance in clinics and hospital settings, and an increasing number of regulatory approvals. For instance, in October 2023, YourBio Health, a Boston-based innovator in remote capillary whole blood collection technology, has disclosed the attainment of additional regulatory approval for its TAP Micro Select blood collection device, securing certification for CE Marking.
By material, plastic was the highest revenue-grossing segment in the global capillary blood collection devices market in 2023 owing to the widespread adoption, user-friendly and cost-effective characteristics, along with the continual introduction of novel products, contribute to the popularity of plastic devices. These devices, commonly utilized in various collection products, are favored for their lightweight nature and biocompatibility with the human body. Over the past few decades, there has been a growing trend in using plastic for manufacturing medical devices. Key factors such as safety, chemical stability, clarity, flexibility, and durability play a significant role in the increasing acceptance of plastic devices in healthcare settings. For instance, in April 2022, Owen Mumford Ltd introduced a new portfolio for venous blood collection under its Unistik brand. Additionally, glass is predicted to grow at fastest CAGR during the forecast period owing to the ease of recyclability, contributing to enhanced environmental sustainability, has led to a growing involvement of manufacturers in producing products and devices based on glass. Glass, distinguished by its high heat resistance, is favored over other materials for manufacturing medical devices. The material's stability, accuracy, and resistance to antimicrobial growth are significant factors driving its widespread adoption.
By application, whole blood tests was the highest revenue-grossing segment in the global capillary blood collection devices market in 2023 owing to Complete blood count (CBC) tests, due to their high frequency and capability to identify a broad spectrum of diseases, are witnessing increased popularity. The prevalence of infectious and chronic diseases like cancer, anemia, autoimmune disorders, and diabetes is on the rise. Additionally, there is a growing trend of collaborations among market players. CBC tests, which are the most commonly performed blood tests, play a crucial role in determining parameters such as white blood cell (WBC) count, red blood cell (RBC) count, hematocrit, hemoglobin, and platelet counts. These tests offer clinicians comprehensive data to identify abnormalities, ensure accurate diagnoses, and are instrumental in monitoring conditions like diabetes and anemia. For instance, in October 2022, BD and Magnolia Medical Technologies Inc have entered into a commercial agreement with the objective of assisting hospitals in the United States to minimize blood culture contamination. This collaboration aims to enhance testing accuracy and, consequently, improve clinical outcomes. Additionally, plasma/ serum protein tests is predicted to grow at fastest CAGR during the forecast period. Plasma tests, also known as protein tests, are employed to assess the levels of proteins in the blood. These tests offer clinicians a comprehensive insight into a patient's health by examining the levels of albumin and globulin. Protein tests are commonly conducted to identify conditions such as liver and kidney disorders, pancreatic disease, intestinal malabsorption, inflammation, nephrotic syndrome, as well as cirrhosis or chronic liver disease.
By end-user, hospitals and clinics was the highest revenue-grossing segment in the global capillary blood collection devices market in 2023 owing to a frequent need for diagnostic testing and a significant influx of patients into these facilities, rising number of surgical procedures, including angioplasty, kidney, and liver transplants, increasing occurrence of trauma injuries, coupled with a heightened research and development expenditure by key industry players. Additionally, home care diagnosis is predicted to grow at fastest CAGR during the forecast period owing to the emergence of innovative devices designed to facilitate convenient and effective diagnosis of diabetic and anemic patients, coupled with a notable increase in partnerships among market players. For instance, in May 2022, Babson Diagnostics, a healthcare technology company focused on scientific advancements, and BD (Becton, Dickinson and Company), a prominent global medical technology company, have expanded their strategic partnership. The collaboration aims to extend blood sample collection to novel care settings, allowing patients to collect blood samples at home for diagnostic testing.
North America region is anticipated for the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, the presence of leading clinical diagnostics firms, growing adoption of advanced technologies, heightened emphasis on clinical research, an increasing number of surgical procedures, a rise in cases related to accidents and trauma, an escalating prevalence of both non-communicable and infectious diseases, and growing launch of innovative devices. For instance, in August 2022, Thermo Fisher Scientific has introduced a new automated system for dried blood spot sampling and analysis. The Thermo Scientific Transcend DSX-1 Integrated Sample Prep and UHPLC System revolutionize the conventional process of dry matrix card punching for sample extraction, accommodating various matrices such as blood, urine, serum, saliva, and more. This system streamlines the collection process, allowing laboratories to efficiently conduct routine analyses of pharmaceuticals and other compounds. The automated system is designed to save substantial time, effort, and reagent costs in comparison to manual workflows. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the escalation in healthcare expenditure, a substantial prevalence of chronic conditions, a surge in health spending, especially for major chronic diseases like diabetes, and an increasing introduction of advanced medical devices. For instance, in September 2022, A team of researchers in South Korea has created a portable, user-friendly, and self-pressure-driven device for blood plasma separation. These devices are designed to work in conjunction with rapid diagnostic test kits.
Segmentation: Capillary Blood Collection Devices Market Report 2023 - 2034
Capillary Blood Collection Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Micro-Hematocrit Tubes
- Micro-Container Tubes
- Warming Devices
- Lancets
- Others
Capillary Blood Collection Devices Market Analysis & Forecast by Material 2023 - 2034 (Revenue USD Bn)
- Stainless Steel
- Ceramic
- Plastic
- Glass
- Others
Capillary Blood Collection Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Liver Panel / Liver Profile/ Liver Function Tests
- Comprehensive Metabolic Panel (CMP) Tests
- Whole Blood
- Plasma/ Serum Protein Tests
- Dried Blood Spot Tests
Capillary Blood Collection Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Blood Donation Centers
- Pathology Laboratories
- Diagnostic Centers
- Hospitals and Clinics
- Home Diagnosis
Capillary Blood Collection Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Capillary Blood Collection Devices Market: Product Estimates & Trend Analysis
8. Capillary Blood Collection Devices Market: Material Estimates & Trend Analysis
9. Capillary Blood Collection Devices Market: Application Estimates & Trend Analysis
10. Capillary Blood Collection Devices Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Capillary Blood Collection Devices Market
13. Europe Global Capillary Blood Collection Devices Market
14. Asia Pacific Global Capillary Blood Collection Devices Market
15. Latin America Global Capillary Blood Collection Devices Market
16. MEA Global Capillary Blood Collection Devices Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- B. Braun Melsungen AG
- Greiner Bio-One International GmbH
- Abbott Laboratories
- Becton
- Dickinson and Company (BD)
- Cardinal Health
- Terumo Medical Corp.
- Improve Medical
- SARSTEDT AG & Co. KG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 1.98 Billion |
| Forecasted Market Value ( USD | $ 5.1 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
